Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Pathogens, Free Full-Text

International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic

Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021

Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis

Frontiers Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland

MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network

ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

Systematic review on the clinical presentation and management of the COVID- 19 associated multisystem inflammatory syndrome in children (MIS-C)

COVID-19 Infection in Children: Diagnosis and Management

Post-acute COVID-19 syndrome

Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review - Frontiers

Multi-system Inflammatory Syndrome in Children (MIS-C) News and Updates

Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C